Drugmaker 
Endo is contemplating its options after peers including 
Conversations with advisers Skadden, PJT and advisory firm 
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
